Testing version — LOERadar is in active testing. Features and data may change.
LAMLIQUE (LAMOTRIGINE HEMIFUMARATE) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
LAMLIQUE
NDANot in Orange Book
LAMOTRIGINE HEMIFUMARATE | N221109 | AZURITY
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — EQ 5MG BASE/ML
▴
SUSPENSION;ORAL | Approved: Sep. 25, 2026
Patents (1)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
12605388Newly listed — daily FDA feed, not yet in monthly Orange Book edition